Model 1 | Model 2 | ||||||
---|---|---|---|---|---|---|---|
Outcome | Effect | Medical status | Groups 1–3 | Age | Groups 1–3×Age | Medical status | Exercise |
Med. Stat. | Direct | – | −0.22 (0.12)† | 0.06 (0.13)† | −0.60 (0.18)†** | – | 0.39 (0.13)†* |
Psychologicalwell-being‡ | Direct | 0.42 (0.18)* | 0.09 (0.13) | 0.15 (0.16) | 0.07 (0.17) | 0.44 (0.16)* | −0.13 (0.14) |
Indirect§ | – | −0.09 (0.06) | 0.03 (0.05) | −0.25 (0.11)* | – | 0.17 (0.10) | |
Total | 0.42 (0.18)* | −0.00 (0.13) | 0.18 (0.16) | −0.18 (0.16) | 0.44 (0.16)* | 0.04 (0.10) | |
CFQ-R Total | Direct | 0.75 (0.13)** | 0.07 (0.13) | 0.37 (0.14)* | 0.04 (0.17) | 0.77 (0.14)** | −0.10 (0.11) |
Indirect§ | – | −0.14 (0.11) | 0.04 (0.09) | −0.42 (0.16)* | – | 0.30 (0.13)* | |
Total | 0.75 (0.13)** | −0.07 (0.13) | 0.41 (0.15)* | −0.38 (0.15)* | 0.77 (0.14)** | 0.20 (0.08)* | |
HADS-Anxiety | Direct | 0.10 (0.19) | 0.13 (0.12) | 0.17 (0.17) | −0.11 (0.19) | 0.14 (0.19) | 0.06 (0.12) |
Indirect§ | – | −0.03 (0.05) | 0.01 (0.02) | −0.06 (0.12) | – | 0.05 (0.07) | |
Total | 0.10 (0.19) | 0.10 (0.11) | 0.18 (0.16) | −0.18 (0.15) | 0.14 (0.19) | 0.11 (0.10) | |
HADS-Depression | Direct | −0.43 (0.21)* | −0.25 (0.13) | −0.19 (0.18) | 0.00 (0.19) | −0.46 (0.18)* | 0.16 (0.17) |
Indirect§ | – | 0.09 (0.06) | −0.02 (0.06) | 0.25 (0.12)* | – | −0.18 (0.11) | |
Total | −0.43 (0.21)* | −0.16 (0.13) | −0.22 (0.17) | 0.25 (0.17) | −0.46 (0.18)* | −0.02 (0.12) |
*p<0.05; ** p<0.001; Note: In model 1, the effects are adjusted for the patients' sex, partner status and educational level. In model 2, the effects are also adjusted for age and cftr gene mutation class.
‡The mean of standardised CFQ-R Total, HADS-Anxiety (reversed) and HADS-Depression (reversed).
§Via medical status.
†With psychological well-being as outcome.
CFQ-R, Cystic Fibrosis Questionnaire-Revised; HADS A and D, Hospital Anxiety and Depression Scale Anxiety and Depression.